Sign in for the best experience.
This sample offers a glimpse into content found in the comprehensive 乐播传媒 Curriculum Pathway for Pulmonary Hypertension (PH). Deepen your knowledge with the best of 乐播传媒 PH resources, including 乐播传媒 SEEK® questions, annual meeting and board review videos, and journal articles, all in one easy-to-access destination.
Advertisement
The patient is a 55鈥恲ear鈥恛ld man with sarcoidosis. He has a mean pulmonary artery pressure of 35 mm Hg, a pulmonary vascular resistance of 6 Wood units, and a pulmonary artery wedge pressure of 10 mm Hg on right heart catheterization.
What group of pulmonary hypertension (PH) would you predict him to have?
A. Group 3: PH in chronic lung disease B. Group 4: chronic thromboembolic pulmonary hypertension C. Group 5: unclear or multifactorial
Answer | Commentary | References
The 2022 European Society of Cardiology/European Respiratory Society clinical classification of PH remains to categorize clinical conditions associated with PH, based on similar pathophysiological mechanisms, clinical presentation, hemodynamic characteristics, and therapeutic management. Sarcoidosis fits within the systemic disorders (5.2) in group 5 (choice C is correct; choices A and B are incorrect).
Klok FA, Couturaud F, Delcroix M, et al. Diagnosis of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Eur Respir J. 2020;55(6):2000189.
To continue reading, please sign in with your 乐播传媒 account.
New to 乐播传媒? Create a free account 禄